ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Machine learning and Mendelian randomization identify key lifestyle factors in coronary heart disease: A NHANES-Based study.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Accuracy of machine learning models for mitral regurgitation severity assessment: A systematic review and meta-analysis.International journal of cardiology. Cardiovascular risk and prevention · 2026Review
- Leakage-Safe Precision-Aware Dual-Branch FT-Transformer for Population-Scale Heart Disease Risk Prediction.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to bridge the gap between predictive modeling and causal inference by utilizing lifestyle data from the National Health and Nutrition Examination Survey (NHANES) database to compare the predictive performance of multiple machine learning models for coronary heart disease (CHD). By incorporating Mendelian randomization, the study seeks to validate and identify the lifestyle variables with both predictive power and causal impact on CHD. Methods: We extracted variables related to demographic characteristics and lifestyle from the NHANES database (2013-2018; n = 29,400). Recursive feature elimination (RFE) was employed to rank variable importance and determine the optimal feature subset. Subsequently, eight machine learning models-including Support Vector Machine (SVM), Neural Network (NN), Naive Bayes (NB), Extreme Gradient Boosting (XGBoost), Multilayer Perceptron (MLP), Generalized Linear Model (GLM), Adaptive Boosting (AdaBoost), and Decision Tree (DT)-were developed for CHD prediction. Model performance was evaluated using metrics such as accuracy, precision, sensitivity, specificity, recall, F1-score, and the Receiver Operating Characteristic (ROC) curve, with variable contributions visualized using Shapley Additive Explanations (SHAP). Additionally, Mendelian randomization (MR) was applied to distinguish associative from causal relationships, validating top predictors via Genome-Wide Association Study (GWAS)-derived genetic instruments. Results: RFE identified age, sex, fasting blood glucose, body mass index (BMI), total cholesterol (TC) intake, sleep duration, diastolic blood pressure, and smoking as the most significant predictors of CHD. Among the models, SVM outperformed DT, AdaBoost, XGBoost, NN, MLP, NB, and GLM. The SVM model achieved the highest performance with an accuracy of 83.4 % and an AUC value of 0.909, demonstrating clinically actionable predictive power. MR confirmed causal associations for five variables: BMI (OR: 1.01, Conclusion: The SVM machine learning model, based on NHANES data, enables faster and more efficient prediction of CHD. The study identified age, sex, BMI, TC intake, sleep duration, diastolic blood pressure, and smoking as the lifestyle variables with the greatest impact on CHD. This dual approach advances precision prevention by combining predictive accuracy with genetic evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.